Pascal and Francis Bibliographic Databases

Help

Search results

Your search

is.\*:("1170-7690")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 755

  • Page / 31
Export

Selection :

  • and

The Problem of Embedded Decision Nodes in Cost-Effectiveness Decision TreesARIAS, Manuel; DIEZ, Francisco Javier.PharmacoEconomics (Auckland). 2014, Vol 32, Num 11, pp 1141-1145, issn 1170-7690, 5 p.Article

Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling ApproachesSHIEN GUO; PELLIGRA, Christopher; THIBAULT, Catherine Saint-Laurent et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 6, pp 559-572, issn 1170-7690, 14 p.Article

Differential Time Preferences for Money and Quality of LifePAROUTY, M. B. Y; LE, H. H; KROOSHOF, D et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 4, pp 411-419, issn 1170-7690, 9 p.Article

Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Myeloid Leukaemia: A Review and Summary of ChallengesMARSH, Kevin; PENG XU; ORFANOS, Panagiotis et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 9, pp 853-864, issn 1170-7690, 12 p.Article

Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic ReviewZUEGER, Patrick M; SCHULTZ, Neil M; LEE, Todd A et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 11, pp 1079-1091, issn 1170-7690, 13 p.Article

Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information OutcomesZAFARI, Zafar; THORLUND, Kristian; FITZGERALD, J. Mark et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 10, pp 995-1004, issn 1170-7690, 10 p.Article

Reconceptualising the External Validity of Discrete Choice ExperimentsLANCSAR, Emily; SWAIT, Joffre.PharmacoEconomics (Auckland). 2014, Vol 32, Num 10, pp 951-965, issn 1170-7690, 15 p.Article

The Health Economics of Bladder Cancer: An Updated Review of the Published LiteratureYEUNG, Christina; DINH, Tuan; LEE, Joseph et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 11, pp 1093-1104, issn 1170-7690, 12 p.Article

The Humanistic Burden of Head and Neck Cancer: A Systematic Literature ReviewWISSINGER, Erika; GRIEBSCH, Ingolf; LUNGERSHAUSEN, Juliane et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 12, pp 1213-1229, issn 1170-7690, 17 p.Article

Impacts of Health Insurance Benefit Design on Percutaneous Coronary Intervention Use and Inpatient Costs among Patients with Acute Myocardial Infarction in Shanghai, ChinaSUWEI YUAN; YAN LIU; NA LI et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 3, pp 265-275, issn 1170-7690, 11 p.Article

The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in ChinaGANG CHEN; LIU, Gordon G; FEI XU et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 3, pp 277-292, issn 1170-7690, 16 p.Article

Evaluating Disease-Modifying Agents: A Simulation Framework for Alzheimer's DiseaseGUO, Shien; GETSIOS, Denis; REVANKAR, Nikhil et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 11, pp 1129-1139, issn 1170-7690, 11 p.Article

A Systematic and Critical Review of the Evolving Methods and Applications of Value of Information in Academia and PracticeSTEUTEN, Lotte; DE WETERING, Gijs Van; GROOTHUIS-OUDSHOORN, Karin et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 1, pp 25-48, issn 1170-7690, 24 p.Article

Dabigatran for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation: A NICE Single Technology AppraisalFARIA, Rita; SPACKMAN, Eldon; BURCH, Jane et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 7, pp 551-562, issn 1170-7690, 12 p.Article

Golimumab for the Treatment of Rheumatoid Arthritis After the Failure of Previous Disease-Modifying Antirheumatic Drugs: A NICE Single Technology AppraisalTOSH, Jonathan; ARCHER, Rachel; DAVIS, Sarah et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 8, pp 653-661, issn 1170-7690, 9 p.Article

Influence of Pharmacogenomic Profiling Prior to Pharmaceutical Treatment in Metastatic Colorectal Cancer on Cost Effectiveness: A Systematic ReviewFRANK, Martin; MITTENDORF, Thomas.PharmacoEconomics (Auckland). 2013, Vol 31, Num 3, pp 215-228, issn 1170-7690, 14 p.Article

Korean Guidelines for Pharmacoeconomic Evaluation (Second and Updated Version): Consensus and CompromiseBAE, Seungjin; LEE, Soook; EUN YOUNG BAE et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 4, pp 257-267, issn 1170-7690, 11 p.Article

Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?MCCABE, Christopher; EDLIN, Richard; HALL, Peter et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 9, pp 731-737, issn 1170-7690, 7 p.Article

Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary Generalization: A NICE Single Technology AppraisalCRAIG, Dawn; RICE, Stephen; PATON, Fiona et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 2, pp 101-110, issn 1170-7690, 10 p.Article

The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering TherapiesREFOIOS CAMEJO, Rodrigo; MCGRATH, Clare; MIRALDO, Marisa et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 5, pp 445-454, issn 1170-7690, 10 p.Article

The Development and Validation of a Decision-Analytic Model Representing the Full Disease Course of Acute Myeloid LeukemiaLEUNIS, Annemieke; KEN REDEKOP, W; VAN MONTFORT, Kees A. G. M et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 7, pp 605-621, issn 1170-7690, 17 p.Article

Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-AnalysisZHAO, Fei-Li; FENG XIE; HAO HU et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 6, pp 501-508, issn 1170-7690, 8 p.Article

Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision MakingFRANKEN, Margreet; NILSSON, Fredrik; SANDMANN, Frank et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 9, pp 781-797, issn 1170-7690, 17 p.Article

Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the USHELLINGER, Fred J.PharmacoEconomics (Auckland). 2013, Vol 31, Num 12, pp 1091-1104, issn 1170-7690, 14 p.Article

How to Include Informal Care in Economic EvaluationsHOEFMAN, Renske J; VAN EXEL, Job; BROUWER, Werner et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 12, pp 1105-1119, issn 1170-7690, 15 p.Article

  • Page / 31